Addiction treatment in Minnesota

On any given week in Minnesota, several hundred residents are hospitalized for overdose. The treatment infrastructure that could prevent most of the deaths behind those hospitalizations is distributed unevenly — 490 facilities concentrated in specific metros, thinning as you move toward the Upper Midwest geography. This is an editorial look at who that serves and who it fails.

The Medicaid question

Minnesota expanded Medicaid in 2014 under the Affordable Care Act. This single policy decision shapes access more than any other single factor. Has realistic access to Medicaid coverage for addiction treatment once enrolled. The states that expanded tend to see meaningfully higher treatment engagement; the states that did not tend to push low-income adults into the state-funded margin, where capacity runs out faster than demand.

The overdose-mortality context

The CDC puts Minnesota's 2023 overdose mortality at 19.4 per 100,000. Whether that number is going up or down week-to-week matters less than where it concentrates, which is uneven: tribal-area access gaps and winter weather barriers in rural north

How access actually works in Minnesota

Inside the 490 licensed facilities in Minnesota, the clinical quality variation is substantial. The practical context here is that tribal-area access gaps and winter weather barriers in rural north — which is why the difference between a well-run IOP and a fee-for-service residential chain that churns patients through 30-day cycles is not visible from the outside. It becomes visible when you ask the specific question: "Does this program offer buprenorphine for opioid use disorder?"

What to do next

In Minnesota, the most underused resource is the PCP. Primary care has expanded its role in addiction treatment substantially since 2020 — buprenorphine prescribing, naltrexone administration, referrals into the evidence-based portion of the network — and a 30-minute PCP appointment often produces more useful direction than a 30-minute call with a treatment-center admissions counselor whose incentives are commercial.